234 related articles for article (PubMed ID: 36785893)
1. Nicotinamide mononucleotide alters body composition and ameliorates metabolic disorders induced by a high-fat diet.
Zhang Y; Zhu W; Wang M; Xi P; Wang H; Tian D
IUBMB Life; 2023 Jun; 75(6):548-562. PubMed ID: 36785893
[TBL] [Abstract][Full Text] [Related]
2. Exercise-induced benefits on glucose handling in a model of diet-induced obesity are reduced by concurrent nicotinamide mononucleotide.
Yu J; Laybutt DR; Kim LJ; Quek LE; Wu LE; Morris MJ; Youngson NA
Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E176-E189. PubMed ID: 34121447
[TBL] [Abstract][Full Text] [Related]
3. Complementary yet divergent effects of exercise and an exercise mimetic on microbiome in high-fat diet-induced obesity.
Yu J; Youngson NA; Laybutt DR; Morris MJ; Leigh SJ
Physiol Genomics; 2024 Feb; 56(2):136-144. PubMed ID: 38009223
[TBL] [Abstract][Full Text] [Related]
4. Function of NAD metabolism in white adipose tissue: lessons from mouse models.
Kwon SY; Park YJ
Adipocyte; 2024 Dec; 13(1):2313297. PubMed ID: 38316756
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise.
Uddin GM; Youngson NA; Doyle BM; Sinclair DA; Morris MJ
Sci Rep; 2017 Nov; 7(1):15063. PubMed ID: 29118320
[TBL] [Abstract][Full Text] [Related]
6. Administration of Nicotinamide Mononucleotide (NMN) Reduces Metabolic Impairment in Male Mouse Offspring from Obese Mothers.
Uddin GM; Youngson NA; Chowdhury SS; Hagan C; Sinclair DA; Morris MJ
Cells; 2020 Mar; 9(4):. PubMed ID: 32218167
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide mononucleotide supplementation protects the intestinal function in aging mice and D-galactose induced senescent cells.
Ru M; Wang W; Zhai Z; Wang R; Li Y; Liang J; Kothari D; Niu K; Wu X
Food Funct; 2022 Jul; 13(14):7507-7519. PubMed ID: 35678708
[TBL] [Abstract][Full Text] [Related]
8. Head to Head Comparison of Short-Term Treatment with the NAD(+) Precursor Nicotinamide Mononucleotide (NMN) and 6 Weeks of Exercise in Obese Female Mice.
Uddin GM; Youngson NA; Sinclair DA; Morris MJ
Front Pharmacol; 2016; 7():258. PubMed ID: 27594836
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men.
Yamaguchi S; Irie J; Mitsuishi M; Uchino Y; Nakaya H; Takemura R; Inagaki E; Kosugi S; Okano H; Yasui M; Tsubota K; Hayashi K; Yoshino J; Itoh H
Endocr J; 2024 Feb; 71(2):153-169. PubMed ID: 38191197
[TBL] [Abstract][Full Text] [Related]
10. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update.
Song Q; Zhou X; Xu K; Liu S; Zhu X; Yang J
Adv Nutr; 2023 Nov; 14(6):1416-1435. PubMed ID: 37619764
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN/NAD consumers mediated by Twist2.
Hasegawa K; Sakamaki Y; Tamaki M; Wakino S
Sci Rep; 2022 Aug; 12(1):13712. PubMed ID: 35962139
[TBL] [Abstract][Full Text] [Related]
12. Depot-specific regulation of NAD
Wei X; Jia R; Wang G; Hong S; Song L; Sun B; Chen K; Wang N; Wang Q; Luo X; Yan J
J Nutr Biochem; 2020 Jun; 80():108377. PubMed ID: 32278117
[TBL] [Abstract][Full Text] [Related]
13. Reduced nicotinamide mononucleotide is a new and potent NAD
Zapata-Pérez R; Tammaro A; Schomakers BV; Scantlebery AML; Denis S; Elfrink HL; Giroud-Gerbetant J; Cantó C; López-Leonardo C; McIntyre RL; van Weeghel M; Sánchez-Ferrer Á; Houtkooper RH
FASEB J; 2021 Apr; 35(4):e21456. PubMed ID: 33724555
[TBL] [Abstract][Full Text] [Related]
14. Improvement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol.
Bai LB; Yau LF; Tong TT; Chan WH; Zhang W; Jiang ZH
Pharmacol Res Perspect; 2022 Aug; 10(4):e00986. PubMed ID: 35844164
[TBL] [Abstract][Full Text] [Related]
15. Alleviation of hepatic insulin resistance and steatosis with NMN via improving endoplasmic reticulum-Mitochondria miscommunication in the liver of HFD mice.
Li Y; Tian X; Yu Q; Bao T; Dai C; Jiang L; Niu K; Yang J; Wang S; Wu X
Biomed Pharmacother; 2024 Jun; 175():116682. PubMed ID: 38703507
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide mononucleotide promotes pancreatic islet function through the SIRT1 pathway in mice after severe burns.
Liu X; Li D; Liu Z; Song Y; Zhang B; Zang Y; Zhang W; Niu Y; Shen C
Burns; 2022 Dec; 48(8):1922-1932. PubMed ID: 35123833
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.
Park JH; Long A; Owens K; Kristian T
Neurobiol Dis; 2016 Nov; 95():102-10. PubMed ID: 27425894
[TBL] [Abstract][Full Text] [Related]
18. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.
Katayoshi T; Uehata S; Nakashima N; Nakajo T; Kitajima N; Kageyama M; Tsuji-Naito K
Sci Rep; 2023 Feb; 13(1):2786. PubMed ID: 36797393
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide mononucleotide ameliorates the depression-like behaviors and is associated with attenuating the disruption of mitochondrial bioenergetics in depressed mice.
Xie X; Yu C; Zhou J; Xiao Q; Shen Q; Xiong Z; Li Z; Fu Z
J Affect Disord; 2020 Feb; 263():166-174. PubMed ID: 31818774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
